Clinical Trials

New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates

Masimo announced the findings of a study published in the European Journal of Pediatrics in which Dr. Masashi Hotta and colleagues at the Osaka Women’s and Children’s...

Theraclion Receives FDA Approval for SONOVEIN Trial

Theraclion has secured FDA (Food & Drug Administration) approval for the first trial with SONOVEIN in the United States (US). After this clinical trial, a full pivotal...

Boston Scientific touts data from Phase 3 study of selective internal radiation therapy

Boston Scientific (NYSE:BSX) touted data from a Phase 3 clinical trial of its TheraSphere Y-90 glass microspheres treatment. In the trial, the TheraSphere treatment successfully met...

Cala Health wearables shown to decrease tremor movement

Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating moments for the non-invasive prescription therapy for essential tremor...

Study Update: OssDsign Synthetic Bone Graft

OssDsign AB (publ) today announced that the first patient has been included in the company’s clinical study TOP FUSION to investigate the long-term safety...

New study demonstrates long-term efficacy of prodisc L total disc replacement

Centinel Spine has announced findings of a new study that it says strongly support the long-term safety and effectiveness of its prodisc L total disc replacement...

Medtronic reports positive CED trial data for Micra TPS leadless pacemaker

The trial assessed patients implanted with Micra VR TPS and with traditional TV-VVI pacemakers. Medtronic has announced new data from the Micra Coverage with Evidence...

NIH Backs Synchron Brain Computer Interface with $10M Grant to Launch First U.S. Clinical Trial

Synchron, a brain data transfer company, announced that the National Institutes of Health (NIH) has awarded a $10M grant for the initiation of the...

Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies

Supporting the Most Robust, Diverse and Longest-Term Body of Clinical Evidence for Any MIGS Technology Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating...
1...474849...58Page 48 of 58

Latest articles